Hepatocellular Carcinoma
Liver Cancer Patients in Austria Seek Care Too Late for Curative Therapy
Published in Hepatitis Weekly, October 16th, 2000
As a result, physicians had little to offer the patients in terms of treatment options, and instead focused on providing therapy that would relieve the patients' suffering.
The results were from a retrospective study of patients who presented with hepatocellular carcinoma to the University of Vienna, Austria, hospital. The number of patients being treated for hepatocellular carcinoma (HCC) at this hospital has been increasing for several years.
Researchers analyzed several characteristics in the 245 hepatocellular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2000-10-16)
More Articles from Hepatitis Weekly
- Risk Factors
Improper Blood Port Cleaning Places Dialysis Patients at Risk for Hepatitis C - Therapy (HBV)
Interferon Limits Expression of Growth Factor in Hepatitis B Patients - Immunization (HBV)
Growth Factor No Enhancer of Hepatitis B Vaccine Efficacy in Renal Patients - Nosocomial Infection
Molecular Testing Identifies Patients Common to Hepatitis B Outbreak - Pharmacoeconomics
Swedish Patients with Chronic Hepatitis Benefit Cost-Wise from Dual Therapy - Prevention
Infants Immunized Against Hepatitis B at Birth Receive Most Vaccine Doses - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
